In the first half of the year, my country's pharmaceutical exports increased by 7.11% at US$25.1 billion

The reporter learned from China Chamber of Commerce for import and export of medical and health products that in the first half of this year, the import and export volume of China's pharmaceutical trade reached 43.237 billion US dollars, an increase of 10.28% year on year Among them, the export volume of pharmaceutical products was 25.144 billion US dollars, an increase of 7.11%, the import volume was 18.093 billion US dollars, an increase of 15.01%, and the foreign trade surplus was 7.051 billion US dollars In the first half of 2013, the global economic growth momentum was insufficient, and the international market demand did not get a fundamental improvement, resulting in the decline of international pharmaceutical trade Xu Ming, vice president of China Chamber of Commerce for the import and export of medical and health care products, said that in view of the adverse changes in the situation, the chamber of Commerce for medical insurance guided and coordinated the industry and enterprises to actively respond, such as coordinating the EU directive 62 and the classification of Customs codes, organizing VC anti monopolization response, organizing CPHI exhibition and other large-scale pharmaceutical exhibitions, and also held a series of key international market trade promotion activities to ease import and export Enterprises are facing difficulties, so as to enhance their confidence The two-level differentiation of export market: the developed market continues to be depressed, and the demand of emerging market is strong Statistics show that in the first half of this year, the export growth rate of China's pharmaceutical products to developed markets such as Europe, the United States and Japan was 3.27%, accounting for 55.26% of the export market, down 2 percentage points from the same period last year The emerging pharmaceutical market is full of vitality China's exports of pharmaceutical products to emerging markets increased by 11.37%, accounting for 24.54% of the total exports, up 1 percentage point from last year The export of preparations has witnessed a rapid growth The export structure has been further optimized, and the tension of export transformation has increased The export of medical devices and characteristic APIs has grown substantially, while the export of Western medicine preparations has grown strongly The export of medical devices grew steadily In the first half of the year, China's medical device export reached 9.011 billion US dollars, a year-on-year increase of 10.87%, accounting for 1.2 percentage points of China's pharmaceutical export, to 35.84% The export volume of characteristic APIs increased rapidly, and the export of preparations will usher in a period of rapid growth According to incomplete statistics, in the first half of the year, China's export of characteristic APIs reached US $1.067 billion, an increase of 11.23% year on year, accounting for more than 80% of its exports to major markets such as India, the United States, the European Union, Japan and South Korea In the first half of the year, the export of Western pharmaceutical preparations reached US $1.357 billion, up 7.93% year on year It is expected that the export of pharmaceutical preparations in the second half of the year will usher in a new round of rapid growth period In the first half of this year, one of the important characteristics of China's pharmaceutical exports is the decline of cost advantage, which weakens the market competitiveness of medical dressings, disposable consumables and other products In the first half of 2013, the export of medical dressings in China ended a long-term double-digit high growth, with a slight increase of 1.01% year-on-year At present, based on the analysis of basic data, the overall medical dressings industry in China is characterized by small market scale, low industry concentration, product homogeneity and low added value With the fierce market competition, the competition of enterprises mainly focuses on the price competition, and the industry is in the stage of low level competition The domestic cotton price is high, and the international competition is intense According to GTA data, Mexico, Brazil, Thailand and India have significantly surpassed China in the export of medical dressings, reaching 11.06%, 7.25%, 21.2% and 66.94% respectively The markets of the United States and the European Union have been occupied and competition has intensified The growth rate of disposable consumables export also fell sharply, only increasing by 8.42% in the first half of this year, compared with 30.53% in the same period of last year Plant extract promotes the export of traditional Chinese medicine According to Xu Ming, vice president of the chamber of Commerce for medical insurance, plant extract and traditional Chinese medicine in China boosted the export of traditional Chinese medicine in the first half of this year In the first half of the year, the export of traditional Chinese medicine rose rapidly, with the export amount of US $1491 million, an increase of 22.49% year on year, showing a trend of volume and price rising, and the increase came from the substantial increase in the export of extracts and traditional Chinese medicine Among them, the domestic price of traditional Chinese medicine materials has been rising continuously in recent two years International customers, especially Japanese, Korean and ASEAN merchants reduced their purchase volume last year, which led to the decrease of inventory in the first half of this year, and then increased the purchase volume, while stimulating the further price rise In the first half of this year, the export price and volume of traditional Chinese medicine increased by 30.44% and 8.24% respectively compared with the same period last year It is expected that this favorable situation will continue in the second half of this year The export price of plant extracts is affected by the rising price of raw materials of traditional Chinese medicine In the first half of this year, the export value of plant extracts reached 694 million US dollars, up 17.16% year on year At present, due to the weakening of the export of traditional Chinese patent medicines, the international market will increase the demand for plant extracts, and the demand of the United States, India, Germany and other international markets will continue to grow Many domestic mainstream pharmaceutical enterprises are optimistic about this situation and are entering or preparing to enter this field, which is expected to effectively promote the further growth of exports of traditional Chinese medicine products.